Akebia Therapeutics News

Latest Akebia Therapeutics Stock News & AKBA Headlines

Akebia Therapeutics, Inc. (AKBA) Q3 2026 Earnings Call Transcript

9 days ago | seekingalpha.com

What Akebia Therapeutics (AKBA) Said on Its Q3 Earnings Call

10 days ago | marketbeat.com

Akebia Therapeutics (AKBA) Reports Q3 Loss, Misses Revenue Estimates

10 days ago | zacks.com

Akebia Therapeutics Reports Third Quarter 2026 Financial Results and Business Highlights

10 days ago | globenewswire.com

Akebia Therapeutics Reports Positive Topline Data from VOCAL Trial Showing Vadadustat Dosed TIW Met Primary Endpoint of Non-Inferiority to ESA in Maintaining Hemoglobin

10 days ago | globenewswire.com

Akebia Therapeutics to Report Third Quarter 2026 Financial Results and Discuss Recent Business Highlights

17 days ago | globenewswire.com

U.S. Renal Care Presents Analysis of VOICE Trial Demonstrating Favorable Safety Outcomes for Patients Treated with Vadadustat Versus an ESA During a Late-Breaking Session at American Society of Nephrology Kidney Week

20 days ago | globenewswire.com

Akebia Therapeutics Announces Late-Breaking VOICE Trial Presentation and Posters on Akebia's Rare Kidney Pipeline at ASN Kidney Week 2026

a month ago | globenewswire.com

Akebia Therapeutics Announces First Patient Dosed in Phase 2 Basket Trial of Ebribafusp in Rare Complement-Mediated Kidney Diseases

2 months ago | globenewswire.com

Akebia Therapeutics to Conduct Investor Meetings at the 2026 Wells Fargo Healthcare Conference in Boston

2 months ago | globenewswire.com

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

Market Closed

AKBA

Akebia Therapeutics

$ 0.4742

-4.78%

Last 24H

Trading with leverage comes with a high risk and may not be suitable for everyone.

Portfolio

Updated a day ago

Top

Gainers

Losers

Symbol

Last Price

24H CNG

Akebia Therapeutics News

Latest Akebia Therapeutics Stock News & AKBA Headlines

Download App

People Also Watch

Explore our Tools